<?xml version="1.0" encoding="UTF-8"?>
<p>The PWID represent no more than an estimated 0.2–0.5% of the world’s population, but they account for approximately 5–10% of all people living with HIV and 6.8% of the persons infected with HCV [
 <xref rid="pone.0185866.ref036" ref-type="bibr">36</xref>, 
 <xref rid="pone.0185866.ref037" ref-type="bibr">37</xref>]. Since 2008 injected amphetamine type stimulants („legal highs”) became available on the market in Romania and were low-priced. As a result, the number of PWID increased dramatically in recent years so that Romania reported an HIV outbreak among PWID that started in 2011; more than 90% of PWID being concentrated in Bucharest and its surroundings [
 <xref rid="pone.0185866.ref010" ref-type="bibr">10</xref>, 
 <xref rid="pone.0185866.ref038" ref-type="bibr">38</xref>]. Numerous people who were injecting heroin have switched to the new class of drugs due to the lower price and because they were legal at that time. An important behavioral characteristic is that the latter require up to 10 injections every day. This fact, which was coincident with an interruption in needle exchange programs, greatly impacted the needle-sharing behavior in the country [
 <xref rid="pone.0185866.ref039" ref-type="bibr">39</xref>]. Preliminary analyses indicated the circulation of CRF14_BG strains in PWID, HIV strains associated with lower CD4 counts and X4 tropism at baseline, as compared with the subtype F1 infected PWID [
 <xref rid="pone.0185866.ref011" ref-type="bibr">11</xref>, 
 <xref rid="pone.0185866.ref040" ref-type="bibr">40</xref>].
</p>
